| Type of cancer | Case by case percent of drugs incompatible with the guidelines = Number of incompatible drugs/Total number of drugs of potential benefit as stated by the test. | |
| Breast Cancer | Case 1 | 12% |
| Case 2 | 15% | |
| Case 3 | 23% | |
| Case 4 | 31% | |
| Case 5 | 21% | |
| Colon Cancer | Case 1 | 38.1% |
| Case 2 | 26.5% | |
| Case 3 | 27% | |
| Liver Cancer | Case 1 | 33.5% |
| Case 2 | 25% | |
| Kidney Cancer | Case 1 | 15% |
| Case 2 | 29% | |
| Cancer Ovary | Case 1 | 1% |
| Case 2 | 2% | |
| Sarcoma | Case 1 | 17% |
| Case 2 | 53.5% | |
| Metastatis of unknown origin | - | |
| Tongue cancer | 35% | |
| Adrenal cancer | 73.2% | |
| Gastric cancer | 27.8% | |
| Lung cancer | 36% | |